The place of chemotherapy associated with active immunotherapy with levamisol in advanced bladder cancer.
D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D007978:Levamisole / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000628:therapy*
D007978:Levamisole; D004317:Doxorubicin; D005472:Fluorouracil